492 filings
Page 16 of 25
8-K
t13lv5 tgrvvkb
18 Mar 09
Medivation Receives Fda Permission to Initiate Phase 3 Trial of MDV3100
12:00am
8-K
f7gvc7
16 Mar 09
Medivation Reports Fourth Quarter and Year-end 2008 Financial
12:00am
CT ORDER
6pcq5bx
6 Mar 09
Confidential treatment order
12:00am
8-K
zlrsiv7ohs2m
25 Feb 09
Medivation Announces New Positive Efficacy Data from Phase 1-2 Trial of
12:00am
S-8
j0lpy1d 61xch0v
30 Jan 09
Registration of securities for employees
12:00am
8-K
gop42fv
20 Jan 09
Departure of Directors or Principal Officers
12:00am
8-K
4qi 7hugs3klze15og
17 Dec 08
Other Events
12:00am
8-K
2qqroph j1
10 Nov 08
Medivation Reports Third Quarter 2008 Financial Results
12:00am
8-K
3rye11w7 f59l
5 Nov 08
Departure of Directors or Principal Officers
12:00am
8-K
tjv6pdumi84n
28 Oct 08
Other Events
12:00am
8-K
mvoamh5
22 Oct 08
Medivation Announces Presentation of 24-WEEK Clinical Data of MDV3100
12:00am
8-K
70hp1es
3 Sep 08
Develop and Market Dimebon for the Treatment of Alzheimer’s
12:00am
8-K
tzhraa9
11 Aug 08
Medivation Reports Second Quarter 2008 Financial Results
12:00am
8-K
ctpe kihw0v
30 Jul 08
Medivation Presents Positive New Data on Dimebon’s Long-term Efficacy
12:00am
8-K
wqd3ul 1xhep
18 Jul 08
Other Events
12:00am
8-K
gnm6xm
7 Jul 08
Medivation Announces Positive Top-line Results from Phase 2
12:00am
8-K
2qk3sixtfoet4jrey
23 Jun 08
Entry into a Material Definitive Agreement
12:00am